Linda Palczuk

CIK 1717580 · Chief Operating Officer · last filed 2026-02-12

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$48.7K

Companies

3

Total Filings

28

Lifetime Open-Market Net

$319.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Director 0 $21.64 $0 $201.7K 23 2026-02-12
VRCA Chief Operating Officer 8,500 $5.73 $48.7K $117.9K 4 2019-03-04
OSIRIS THERAPEUTICS, INC. (OSIR) Delisted President & CEO $0 1 2017-09-21

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-12-05 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +7,500 $44.3K EDGAR
2019-08-09 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) $0 EDGAR
2019-03-04 VRCA Grant (A) $0 EDGAR
2019-01-17 VRCA Buy (P) +3,000 $31.6K EDGAR
2018-09-18 VRCA Buy (P) +2,500 $41.3K EDGAR
2018-08-15 VRCA Buy (P) +3,000 $45.0K EDGAR
2018-08-02 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +27,900 $0 EDGAR
2017-09-21 OSIRIS THERAPEUTICS, INC. (OSIR) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.